
HCW Biologics Inc. (NASDAQ:HCWB) shares skyrocketed 102.72% to $6.73 in after-hours trading on Thursday following the company’s announcement of the successful development of second-generation T-cell engagers targeting solid tumors.
Check out the current price of HCWB stock here.